Personal tools

Coexpression cluster:C514: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|gostat_on_coexpression_clusters=GO:0006954!inflammatory response!0.00647906594947299!8605;8767;6401$GO:0009611!response to wounding!0.00983701397986704!8605;8767;6401$GO:0008903!hydroxypyruvate isomerase activity!0.0127385733489111!81888$GO:0006952!defense response!0.0127385733489111!8605;8767;6401$GO:0009605!response to external stimulus!0.0129117202217266!8605;8767;6401$GO:0046475!glycerophospholipid catabolic process!0.0150696823597155!8605$GO:0047499!calcium-independent phospholipase A2 activity!0.0193733097010132!8605$GO:0019369!arachidonic acid metabolic process!0.022599866037022!8605$GO:0050700!CARD domain binding!0.0271142515575275!8767$GO:0030274!LIM domain binding!0.0271142515575275!8767$GO:0007567!parturition!0.0328589881048493!8605$GO:0006950!response to stress!0.0363166120593536!8605;8767;6401$GO:0009395!phospholipid catabolic process!0.045157841689947!8605$GO:0042809!vitamin D receptor binding!0.048153480631656!9862$GO:0016455!RNA polymerase II transcription mediator activity!0.048153480631656!9862
|gostat_on_coexpression_clusters=GO:0006954!inflammatory response!0.00647906594947299!8605;8767;6401$GO:0009611!response to wounding!0.00983701397986704!8605;8767;6401$GO:0008903!hydroxypyruvate isomerase activity!0.0127385733489111!81888$GO:0006952!defense response!0.0127385733489111!8605;8767;6401$GO:0009605!response to external stimulus!0.0129117202217266!8605;8767;6401$GO:0046475!glycerophospholipid catabolic process!0.0150696823597155!8605$GO:0047499!calcium-independent phospholipase A2 activity!0.0193733097010132!8605$GO:0019369!arachidonic acid metabolic process!0.022599866037022!8605$GO:0050700!CARD domain binding!0.0271142515575275!8767$GO:0030274!LIM domain binding!0.0271142515575275!8767$GO:0007567!parturition!0.0328589881048493!8605$GO:0006950!response to stress!0.0363166120593536!8605;8767;6401$GO:0009395!phospholipid catabolic process!0.045157841689947!8605$GO:0042809!vitamin D receptor binding!0.048153480631656!9862$GO:0016455!RNA polymerase II transcription mediator activity!0.048153480631656!9862
|id=C514
|id=C514
|ontology_enrichment_celltype=CL:0000115!3.11e-13!35;CL:0002139!2.17e-12!24;CL:0002078!5.92e-12!44;CL:0000213!1.03e-09!57;CL:0000215!1.03e-09!57;CL:0000071!1.61e-08!18;CL:0002546!1.61e-08!18
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0004111!2.88e-21!241;UBERON:0007023!1.73e-18!115;UBERON:0000025!2.53e-18!194;UBERON:0000477!6.14e-18!286;UBERON:0000480!1.59e-17!626;UBERON:0000467!3.25e-17!625;UBERON:0000468!7.40e-17!659;UBERON:0000055!1.30e-15!69;UBERON:0003914!2.56e-15!118;UBERON:0000922!8.58e-15!612;UBERON:0002050!2.65e-13!605;UBERON:0005423!2.65e-13!605;UBERON:0000923!3.22e-13!604;UBERON:0005291!3.22e-13!604;UBERON:0006598!3.22e-13!604;UBERON:0002532!3.22e-13!604;UBERON:0002049!9.08e-13!79;UBERON:0007798!9.08e-13!79;UBERON:0001981!5.06e-12!60;UBERON:0007500!5.06e-12!60;UBERON:0004537!5.06e-12!60;UBERON:0006965!5.06e-12!60;UBERON:0001009!2.80e-11!113;UBERON:0000483!4.04e-11!309;UBERON:0000119!7.11e-11!312;UBERON:0004872!1.45e-10!84;UBERON:0004535!1.64e-10!110;UBERON:0000481!5.03e-09!347;UBERON:0001986!1.61e-08!18;UBERON:0004638!1.61e-08!18;UBERON:0004852!1.61e-08!18;UBERON:0005177!3.07e-08!107;UBERON:0005172!7.71e-08!55;UBERON:0005173!7.71e-08!55;UBERON:0000926!9.32e-08!448;UBERON:0004120!9.32e-08!448;UBERON:0006603!9.32e-08!448;UBERON:0001637!1.21e-07!42;UBERON:0003509!1.21e-07!42;UBERON:0004572!1.21e-07!42;UBERON:0003081!1.38e-07!216;UBERON:0000490!1.86e-07!138;UBERON:0000062!5.46e-07!511
}}
}}

Revision as of 14:54, 21 May 2012


Full id: C514_Lymphatic_Endothelial_mycosis_appendix_heart_CD14_migratory



Phase1 CAGE Peaks

Hg19::chr12:47053880..47053887,+p@chr12:47053880..47053887
+
Hg19::chr15:89736241..89736275,+p@chr15:89736241..89736275
+
Hg19::chr17:28534879..28534889,-p@chr17:28534879..28534889
-
Hg19::chr17:28534912..28534942,-p@chr17:28534912..28534942
-
Hg19::chr17:38179836..38179841,-p3@MED24
Hg19::chr17:45933057..45933064,-p3@SP6
Hg19::chr17:75873825..75873826,+p@chr17:75873825..75873826
+
Hg19::chr19:48613987..48613999,-p5@PLA2G4C
Hg19::chr1:169703213..169703227,-p1@SELE
Hg19::chr1:43917566..43917577,-p6@HYI
Hg19::chr4:114238344..114238353,+p58@ANK2
Hg19::chr4:38057520..38057536,-p@chr4:38057520..38057536
-
Hg19::chr4:38057595..38057624,-p@chr4:38057595..38057624
-
Hg19::chr4:38057720..38057727,-p@chr4:38057720..38057727
-
Hg19::chr6:29527501..29527515,-p1@UBD
Hg19::chr8:80680913..80680917,-p@chr8:80680913..80680917
-
Hg19::chr8:90769563..90769576,-p1@ENST00000523859
Hg19::chr8:90769801..90769825,+p4@RIPK2


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0006954inflammatory response0.00647906594947299
GO:0009611response to wounding0.00983701397986704
GO:0008903hydroxypyruvate isomerase activity0.0127385733489111
GO:0006952defense response0.0127385733489111
GO:0009605response to external stimulus0.0129117202217266
GO:0046475glycerophospholipid catabolic process0.0150696823597155
GO:0047499calcium-independent phospholipase A2 activity0.0193733097010132
GO:0019369arachidonic acid metabolic process0.022599866037022
GO:0050700CARD domain binding0.0271142515575275
GO:0030274LIM domain binding0.0271142515575275
GO:0007567parturition0.0328589881048493
GO:0006950response to stress0.0363166120593536
GO:0009395phospholipid catabolic process0.045157841689947
GO:0042809vitamin D receptor binding0.048153480631656
GO:0016455RNA polymerase II transcription mediator activity0.048153480631656



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
anatomical conduit2.88e-21241
adult organism1.73e-18115
tube2.53e-18194
anatomical cluster6.14e-18286
anatomical group1.59e-17626
anatomical system3.25e-17625
multi-cellular organism7.40e-17659
vessel1.30e-1569
epithelial tube2.56e-15118
embryo8.58e-15612
embryonic structure2.65e-13605
developing anatomical structure2.65e-13605
germ layer3.22e-13604
embryonic tissue3.22e-13604
presumptive structure3.22e-13604
epiblast (generic)3.22e-13604
vasculature9.08e-1379
vascular system9.08e-1379
blood vessel5.06e-1260
epithelial tube open at both ends5.06e-1260
blood vasculature5.06e-1260
vascular cord5.06e-1260
circulatory system2.80e-11113
epithelium4.04e-11309
cell layer7.11e-11312
splanchnic layer of lateral plate mesoderm1.45e-1084
cardiovascular system1.64e-10110
multi-tissue structure5.03e-09347
endothelium1.61e-0818
blood vessel endothelium1.61e-0818
cardiovascular system endothelium1.61e-0818
trunk region element3.07e-08107
abdomen element7.71e-0855
abdominal segment element7.71e-0855
mesoderm9.32e-08448
mesoderm-derived structure9.32e-08448
presumptive mesoderm9.32e-08448
artery1.21e-0742
arterial blood vessel1.21e-0742
arterial system1.21e-0742
lateral plate mesoderm1.38e-07216
unilaminar epithelium1.86e-07138
organ5.46e-07511


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.